Williams Jones & Associates’s Edwards Lifesciences EW Stock Holding History

Williams Jones & Associates’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$419K	Buy	6,807 +108	+2%	+$6.53K	0.01%	282
2019 Q1	$427K	Hold	6,699	–	–	0.01%	290
2018 Q4	$342K	Hold	6,699	–	–	0.01%	296
2018 Q3	$389K	Buy	6,699 +360	+6%	+$17.6K	0.01%	326
2018 Q2	$308K	Sell	6,339 -165	-3%	-$7.7K	0.01%	353
2018 Q1	$302K	Buy	6,504 +705	+12%	+$30.6K	0.01%	349
2017 Q4	$218K	Buy	+5,799	New	+$213K	﹤0.01%	398

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Williams Jones & Associates's EW Position: Q2 2019 in Review

Williams Jones & Associates increased its Edwards Lifesciences (EW) stake by 1.6% in Q2 2019, buying an estimated $6.53K and bringing the position to 6,807 shares worth $419K. The position accounts for 0.01% of the portfolio, ranked #282.

Williams Jones & Associates first reported a position in EW in Q4 2017 and has held it in 7 quarters since. The position peaked at $427K in Q1 2019. 921 funds tracked by Wall St. Rank hold EW as of Q2 2019.

Williams Jones & Associates held 6,807 shares of Edwards Lifesciences worth $419K as of Q2 2019.
Williams Jones & Associates bought 108 Edwards Lifesciences shares in Q2 2019, an estimated $6.53K.
Edwards Lifesciences made up 0.01% of Williams Jones & Associates's portfolio in Q2 2019, its #282 holding.
Williams Jones & Associates first reported a position in Edwards Lifesciences in Q4 2017 and has held it in 7 quarters since.
Williams Jones & Associates's Edwards Lifesciences position peaked at $427K in Q1 2019.
921 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2019.

Based on Williams Jones & Associates's 13F filing for Q2 2019, filed 14 Aug 2019.